Allosteric modulators of MEK1: drug design and discovery.
about
The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.Dependence of prevalence of contiguous pathways in proteins on structural complexity.Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.
P2860
Allosteric modulators of MEK1: drug design and discovery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Allosteric modulators of MEK1: drug design and discovery.
@en
type
label
Allosteric modulators of MEK1: drug design and discovery.
@en
prefLabel
Allosteric modulators of MEK1: drug design and discovery.
@en
P2093
P2860
P356
P1476
Allosteric modulators of MEK1: drug design and discovery.
@en
P2093
Jialin Shang
Jian Zhang
Shaoyong Lu
Yongjun Jiang
P2860
P304
P356
10.1111/CBDD.12780
P577
2016-04-26T00:00:00Z